| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |